Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215249 | 0.95 | ALDH1A1 (0.34) | ALDH1A1NPSR1 | |
| SCHEMBL1496206 | 0.95 | ALDH1A1 (0.34) | ALDH1A1NPSR1 | |
| SCHEMBL3781981 | 0.79 | — | — | |
| SCHEMBL5188257 | 0.76 | — | — | |
| SCHEMBL24477676 | 0.73 | ALDH1A1 (0.37) | ALDH1A1NPSR1 | |
| SCHEMBL4931071 | 0.73 | ALDH1A1 (0.37) | ALDH1A1NPSR1 | |
| SCHEMBL6899186 | 0.73 | ALDH1A1 (0.37) | ALDH1A1NPSR1 | |
| SCHEMBL14721823 | 0.73 | ALDH1A1 (0.37) | ALDH1A1NPSR1 | |
| SCHEMBL14721640 | 0.71 | — | — | |
| SCHEMBL26937043 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10006151-B2 | Polyurethane fiber | TORAY OPELONTEX CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-2947185-B1 | POLYURETHANE FIBER AND ITS USE | TORAY OPELONTEX CO LTD (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-20160002827-A1 | POLYURETHANE FIBER | TORAY OPELONTEX CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2947185-A1 | POLYURETHANE FIBER | Toray Opelontex Co., Ltd (JP) | 2015-11-25 | — | — | EP | disclosed |
| EP-1652834-B1 | Process for producing salicylic esters | KAO CORP (JP) | 2008-10-01 | — | — | EP | disclosed |
| EP-1652834-A1 | Process for producing salicylic esters | KAO CORPORATION (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-20060058547-A1 | Process for producing salicylic esters | KAO CORPORATION (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1634571-A1 | Transesterification process for producing salicylic esters used in perfumes | KAO CORPORATION (JP) | 2006-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058547-A1 | Process for producing salicylic esters | NOTUM, FASN, AGPS | ALDH1A1 268/4885NPSR1 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.